Introductory Summary of Mannitol Inhalation Test

Introductory Summary of Mannitol Inhalation Test

Mannitol inhalation is used in patients six years old and older to help diagnose asthma. It’s used in a process known as a bronchial challenge test to help you as a doctor quantify the impact of the medicine in the patient’s lungs and assess if they suffer from breathing problems.

Choosing to participate in the mannitol inhalation test is a decision you and your patient will make. With this evaluation, the following ought to be considered:

If the patient has allergies to foods, dyes, preservatives, or animal fur, the mannitol test may not be advisable.

Patients under six shouldn’t be given mannitol.

There are no adequate studies in girls for discovering danger to the infant when using this medicine during breastfeeding. You and the patient should weigh the possible benefits against the potential risks.

Medication Interactions:
Patients should let you know if they’re taking any of the medications. Certain medications can cause a negative reaction. Other medications may be used jointly with the mannitol test, but the dosage or frequency may need to be changed.

Food and Other Substances:
Certain medicines shouldn’t be utilized in or around the time of ingesting meals or eating certain kinds of food because interactions might happen. Using tobacco or alcohol with specific medications could also cause interactions to occur. Ask the patient if they use their medicines with meals, alcohol, or tobacco.

Other Medical Issues:
Other medical issues may interfere with the effectiveness or safety of mannitol. These conditions include but are not limited to:

Angina (acute chest pain)
Respiratory difficulties (e.g., ventilatory disability )
Pneumothorax (gas or air in the torso )
Breathing difficulty through the spirometry test
Recent surgery in the torso region
Hypertension (elevated blood pressure)
Recent stroke
Kidney disease

Proper Utilization
Mannitol can be used with a specific inhaler to assess the medicine’s impact on the lungs. You, as the doctor or a trained member of your team should be with the patient during the entire process. The completion of the evaluation will permit you to know whether or not the patient has asthma.

To perform the mannitol evaluation:
Before performing the bronchial challenge test, request that the patient executes a lung or breathing evaluation (e.g., spirometry test).

During the test, a nose clip will be going to be placed in your nose so you’ll only be able to breathe from the mouth.

Put a 1% capsule into the inhaler.

To inhale the medication, the patient should breathe out completely, attempting to get as much air from the lungs as they can. They should place the inhaler just in front of their mouth.

They should then hold their breath for approximately 5 seconds, then inhale slowly before removing the nose clip.

They will need to complete the above steps around eight times (a total of 9 rising doses). This is to assess the impact of mannitol on your lungs.

As soon as they’ve completed the exam, they’ll be provided a short-acting inhaler that will help them breathe (for individuals with a positive outcome).

Dispose of the inhaler after use.

Mannitol Inhalation Powder is the active ingredient in Aridol. It is Indicated for the assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma.


David Lockhart